NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY
Amlodipine combines the most important clinical effects of calcium antagonists with minimal side effects of both its ATC class and drugs of previous generations. Its high antihypertensive activity is not in doubt. Proven ability to improve long-term prognosis is a priority when choosing of amlodip...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/112 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849228009127542784 |
|---|---|
| author | A. V. Rudenko B. A. Rudenko |
| author_facet | A. V. Rudenko B. A. Rudenko |
| author_sort | A. V. Rudenko |
| collection | DOAJ |
| description | Amlodipine combines the most important clinical effects of calcium antagonists with minimal side effects of both its ATC class and drugs of previous generations. Its high antihypertensive activity is not in doubt. Proven ability to improve long-term prognosis is a priority when choosing of amlodipine for treatment of hypertensive patients. This is particularly important for the primary prevention in the presence of both risk factors and associated clinical conditions. Amlodipine therapy significantly reduced cardiovascular events incidence in patients with atherosclerosis, even if they have no arterial hypertension. The likely rationales for this amlodipine effect are its vasoprotective properties, ability to re- duce vascular stiffness and to slow down the progression of atherosclerosis. |
| format | Article |
| id | doaj-art-4c472b0cc1e0494da28a6406cb5eb620 |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2015-09-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-4c472b0cc1e0494da28a6406cb5eb6202025-08-23T10:00:16ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-019444845410.20996/1819-6446-2013-9-4-448-454111NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORYA. V. Rudenko0B. A. Rudenko1Russian Cardiology Research and Production Complex, MoscowState Research Center for Preventive Medicin, MoscowAmlodipine combines the most important clinical effects of calcium antagonists with minimal side effects of both its ATC class and drugs of previous generations. Its high antihypertensive activity is not in doubt. Proven ability to improve long-term prognosis is a priority when choosing of amlodipine for treatment of hypertensive patients. This is particularly important for the primary prevention in the presence of both risk factors and associated clinical conditions. Amlodipine therapy significantly reduced cardiovascular events incidence in patients with atherosclerosis, even if they have no arterial hypertension. The likely rationales for this amlodipine effect are its vasoprotective properties, ability to re- duce vascular stiffness and to slow down the progression of atherosclerosis.https://www.rpcardio.online/jour/article/view/112amlodipinearterial hypertensioncardiovascular complications |
| spellingShingle | A. V. Rudenko B. A. Rudenko NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY Рациональная фармакотерапия в кардиологии amlodipine arterial hypertension cardiovascular complications |
| title | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY |
| title_full | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY |
| title_fullStr | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY |
| title_full_unstemmed | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY |
| title_short | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY |
| title_sort | norvasc r in russia 20 years later continuation of the history |
| topic | amlodipine arterial hypertension cardiovascular complications |
| url | https://www.rpcardio.online/jour/article/view/112 |
| work_keys_str_mv | AT avrudenko norvascinrussia20yearslatercontinuationofthehistory AT barudenko norvascinrussia20yearslatercontinuationofthehistory |